BridgeBio Pharma Inc (BBIO) Insider Trading
- $127,912,608.53
- $386,824,513.53
- March 1, 2024
- Neil Kumar
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 4, 2020 | Insider | 1,494 | $30.00 | Sell | $44,820.00 | |
| May 1, 2020 | Insider | 7,200 | $29.23 | Sell | $210,456.00 | |
| April 27, 2020 | Insider | 2,000 | $32.01 | Sell | $64,020.00 | |
| April 8, 2020 | Insider | 8,000 | $27.04 | Sell | $216,320.00 | |
| April 7, 2020 | CEO | 1,805 | $25.48 | Sell | $45,991.40 | |
| April 3, 2020 | CEO | 300 | $25.09 | Sell | $7,527.00 | |
| April 1, 2020 | Insider | 2,585 | $26.94 | Sell | $69,639.90 | |
| April 1, 2020 | CEO | 62,117 | $26.26 | Sell | $1,631,192.42 | |
| Feb. 11, 2020 | Insider | 2,000 | $37.28 | Sell | $74,560.00 | |
| Feb. 10, 2020 | Chairman | 20,000 | $36.00 | Sell | $720,000.00 | |
| Feb. 5, 2020 | CEO | 30,893 | $34.87 | Sell | $1,077,238.91 | |
| Jan. 14, 2020 | Chairman | 10,000 | $35.00 | Sell | $350,000.00 | |
| Jan. 8, 2020 | Insider | 12,807 | $34.37 | Sell | $440,176.59 | |
| Jan. 2, 2020 | Insider | 3,617 | $33.26 | Sell | $120,301.42 | |
| Dec. 30, 2019 | Chairman | 17,150 | $35.80 | Sell | $613,970.00 | |
| Dec. 27, 2019 | Chairman | 82,850 | $37.92 | Sell | $3,141,672.00 | |
| July 1, 2019 | Major Shareholder | 2,647,100 | $17.00 | Buy | $45,000,700.00 | |
| July 1, 2019 | Insider | 55,500 | $17.00 | Buy | $943,500.00 | |
| June 28, 2019 | Insider | 1,000 | $3.43 | Buy | $3,430.00 | |
| June 27, 2019 | Major Shareholder | 4,705,900 | $17.00 | Buy | $80,000,300.00 |
Insiders are both buying and selling BridgeBio Pharma Inc stock.
The insider traders at BridgeBio Pharma Inc are: Neil Kumar, Brian C Stephenson, Cameron Turtle, Michael Thomas Henderson, Genetic Disorder L.P. Kkr, Charles J. Homcy, Frank Mccormick, Randal W Scott, Richard H Scheller, Douglas A Dachille, Charles J Homcy, Global Investors Lp Viking, Ronald J Daniels, Brian C. Stephenson, and Hannah Valantine
The most active insider trader at BridgeBio Pharma Inc is Neil Kumar with 16 trades.
Genetic Disorder L.P. Kkr has sold the most BridgeBio Pharma Inc stock with a total value of $497,034,749.10.
Global Investors Lp Viking has bought the most BridgeBio Pharma Inc stock with a total value of $160,000,600.00.
The most recent insider trade for BridgeBio Pharma Inc was on March 1, 2024.
The single biggest insider buy for BridgeBio Pharma Inc was from Global Investors Lp Viking with a total value of $80,000,300.00 on June 27, 2019.
The single biggest insider sell for BridgeBio Pharma Inc was from Genetic Disorder L.P. Kkr with a total value of $208,621,500.00 on Feb. 17, 2021.